A Pilot Study Of Ga-68-DOTA-TOC Imaging In Participants With Small Bowel Carcinoid Tumors

Condition:   Small Bowel Carcinoid Tumor Interventions:   Drug: Ga-68-DOTA-TOC;   Device: Siemens PET/MR scanner;   Other: Standard Siemens Software;   Drug: LAR Octreotide Sponsor:   Massachusetts General Hospital Not yet recruiting - verified February 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials